Surgery: light – thermal – and electrical application – Light – thermal – and electrical application – Electrical therapeutic systems
Reexamination Certificate
2007-03-13
2007-03-13
Manuel, George (Department: 3762)
Surgery: light, thermal, and electrical application
Light, thermal, and electrical application
Electrical therapeutic systems
Reexamination Certificate
active
09980908
ABSTRACT:
Electrical treatment apparatus (100) for use with an associated molecule source, comprising: at least one electrode (106); a power source (120) for electrifying said at least one electrode; and a controller, which is programmed to activate the power source (120) to selectively electrify said at least one electrode (106) to apply at least one electric field including a transport effect for transporting a molecule in a desired manner and a non-excitatory control effect for controlling the activity of at least apart of a heart, said programming selected to achieve a desired provision of said molecule into at least a portion of a patient's heart or associated vasculature.
REFERENCES:
patent: 4164216 (1979-08-01), Person
patent: 4273114 (1981-06-01), Barkalow et al.
patent: 5026397 (1991-06-01), Aoki et al.
patent: 5087243 (1992-02-01), Avitall
patent: 5236413 (1993-08-01), Feiring
patent: 5282785 (1994-02-01), Shapland et al.
patent: 5286254 (1994-02-01), Shapland et al.
patent: 5327887 (1994-07-01), Nowakowski
patent: 5386837 (1995-02-01), Sterzer
patent: 5387419 (1995-02-01), Levy et al.
patent: 5415629 (1995-05-01), Henley
patent: 5419763 (1995-05-01), Hildebrand
patent: 5445609 (1995-08-01), Lattin et al.
patent: 5458568 (1995-10-01), Racchini et al.
patent: 5499971 (1996-03-01), Shapland et al.
patent: 5501662 (1996-03-01), Hofmann
patent: 5634895 (1997-06-01), Igo et al.
patent: 5634899 (1997-06-01), Shapland et al.
patent: 5779661 (1998-07-01), Stephen et al.
patent: 5807306 (1998-09-01), Shapland et al.
patent: 5865787 (1999-02-01), Shapland et al.
patent: 6041252 (2000-03-01), Walker et al.
patent: 6057374 (2000-05-01), Huntington et al.
patent: 6071305 (2000-06-01), Brown et al.
patent: 6086582 (2000-07-01), Altman et al.
patent: 6292704 (2001-09-01), Malonek et al.
patent: 6298268 (2001-10-01), Ben-Haim et al.
patent: 6949081 (2005-09-01), Chance
patent: 2005/0192542 (2005-09-01), Dev et al.
patent: WO 92/00716 (1992-01-01), None
patent: WO 95/08316 (1995-03-01), None
patent: WO 97/25098 (1997-07-01), None
patent: WO 98/15317 (1998-04-01), None
patent: WO 99/03533 (1999-01-01), None
patent: WO 99/24110 (1999-05-01), None
patent: WO 99/29307 (1999-06-01), None
patent: WO 99/55360 (1999-11-01), None
patent: WO 99/59548 (1999-11-01), None
patent: WO 00/16741 (2000-03-01), None
patent: WO 00/53257 (2000-09-01), None
Patterson, C. et al.; “Therapeutic Angiogenesis—The New Electrophysiology?;” May 25, 1999; pp. 2614-2616; Circulation; 1999 American Heart Association, Inc.
Tsong, T. Y.; “Electroporation of Cell Membranes;” Aug. 1991; pp. 297-306; Biophysical Journal; vol. 60.
Sukhorukov, V. L. et al.; “The Effect of Electrical Deformation Forces on the Electropermeabilization of Erythrocyte Membranes in Low- and High-Conductivity Media;” 1998; pp. 235-245; The Journal of Membrane Biology; vol. 163.
Gussonl, E. et al.; “Dystrophia Expression in the MDX Mouse Restored by Stem Cell Transplantation;” Sep. 23, 1999; pp. 390-394; Nature; vol. 401; No. 6751.
Cano, N. J. et al.; “Dose-Dependent Reversal of Digoxin-Inhibited Activity of an In-Vitro Na+K+ATPase Model by Digoxin-Specific Antibody;” May 1996; pp. 107-1011; Toxicology Letters;; vol. 85; No. 2.
Moran, R. J. et al.; “Digoxin-Specific Fab Fragments Impair Renal Function in the Rat;” 1994; pp. 854-856; Journal of Pharmacy and Pharmacology; vol. 46; No. 10.
Antman, E. M. et al.; “Treatment of 150 Cases of Life-Threatening Digitals Intoxication with Digoxin-Specific Fab Antibody Fragments;” Jun. 1990;Circulation; vol. 81; No. 6; pp. 1744-1752.
Shumaik, G. M. et al; “Oleander Poisoning: Treatment with Digoxin-Specific Fab Antibody Fragments;” Jul. 1988; pp. 732-735; Annals of Emergency Medicine; vol. 17; No. 7.
Darvish Nissim
Shemer Itzhak (Itrik)
Impulse Dynamics NV
Manuel George
LandOfFree
Drug delivery device does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Drug delivery device, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Drug delivery device will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3723489